Pre-market top gainer: CHM.AX Chimeric Therapeutics ASX +33% 04 Mar 2026: catalyst

The CHM.AX stock surged 33.33% in pre-market trade to A$0.002 on 04 Mar 2026, making Chimeric Therapeutics Limited a top gainer on the ASX. Volume climbed to 1,609,843.00 shares versus a 50-day average, driving a short squeeze in this microcap biotech. The move follows renewed investor interest in Chimeric’s early-stage clinical programs and leaves the stock well off its A$0.009 year high, keeping volatility and upside potential high for short-term traders.